(Coppola et al., 2018) More recently, the novel dual CCR2/5 inhibitor BMS-687681 was proved to block hepatic infiltration of inflammatory monocytes in murine NASH models. The gene discussed is CCR2; the disease is metabolic dysfunction-associated steatohepatitis.